MEDICOPRECIS
Board
2 directors, 1 in day-to-day management, last change in 2025Director
since 12-06-2025
6-year term from 2025
earlier managing director, from 25-01-2021 to 16-12-2022
listed in the 2025 annual accounts, filed on 29-06-2026
Director and managing director
director since 12-06-2025
managing director appointed by deed of 16-12-2022
6-year term from 2025
listed in the 2025 annual accounts, filed on 29-06-2026
- Sébastien De la haye
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Artikel 20: Vertegenwoordigding van de vennootschap Alle akten die de vennootschap verbinden, in en buiten rechte, zijn gel-dig wanneer zij…”deed of 28-03-2024
Mandates through the years
3 names, the dashed line is todayLeadershipBoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
- Martine Rooze
- Director, from 19-06-2019 to date
- Managing director, appointed by deed of 25-01-2021, until 16-12-2022
- Sébastien De la haye
- Director, from 19-06-2019 to date
- Managing director, appointed by deed of 16-12-2022, still in office
- Edmond C. De la haye
- Director, until 11-10-2020
Control
Capital
- Capital
- €2,300,000
- Shares
- 53,961
- Contribution per share
- €42.62
- Equity per share
- €3.22 in 2025
- Source
- deed of 28-03-2024
Articles of association
deed of 28-03-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Wednesday of June at 18:00